Origin and diversification of steroids: Co-evolution of enzymes and nuclear receptors by Michael E. Baker
  
Origin and diversification of steroids: Co-evolution of enzymes and nuclear receptors 
 
Michael E. Baker 
Department of Medicine, 0693 
University of California, San Diego 
9500 Gilman Drive 
La Jolla, California 92093-0693 
E-mail: mbaker@ucsd.edu 
Phone: 858-534-8317 
Fax: 858-822-0873 
 
 
Summary Recent sequencing of amphioxus and sea urchin genomes has provided important data 
for understanding the origins of enzymes that synthesize adrenal and sex steroids and the 
receptors that mediate physiological response to these vertebrate steroids.  Phylogenetic 
analyses reveal that CYP11A and CYP19, which are involved in the synthesis of adrenal and sex 
steroids, first appear in the common ancestor of amphioxus and vertebrates.  This correlates 
with recent evidence for the first appearance in amphioxus of receptors with close similarity to 
vertebrate steroid receptors.  Other CYP450 enzymes involved in steroid synthesis can be 
traced back to invertebrates, in which they have at least two functions: detoxifying xenobiotics 
and catalyzing the synthesis of sterols that activate nuclear receptors.  CYP450 metabolism of 
hydrophobic xenobiotics may have been a key event in the origin of ligand-activated steroid 
receptors from constitutively active nuclear receptors. 
 
 
Introduction 
This review of the origin and diversification of steroids focuses on adrenal and sex 
steroids - aldosterone, cortisol, estradiol (E2), progesterone and testosterone -, which regulate a 
wide range of physiological processes including reproduction, development and homeostasis 
[Figure 1].  Because the physiological actions of these vertebrate steroids are mediated by 
nuclear receptors, a large and diverse group of transcription factors that arose in multicellular 
animals [1-3], the origin and diversification of steroids involves the co-evolution of enzymes that 
synthesize steroids from cholesterol [4-5] [Figure 2] and the receptors that mediate their 
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responses [1-2,6-7].  In this manuscript, steroids and steroid receptors refer to vertebrate 
steroids and their nuclear receptors, which are different from ecdysteroids and the ecdysone 
receptor [EcR] [2,8-9]. 
Important in the orgins and evolution of vertebrate steroids are two important classes of 
enzymes, cytochrome P450s [CYP450s] [10-12] and hydroxysteroid dehydrogenases [HSDs] 
[13-15], which are involved in the synthesis of biologically active steroids from cholesterol.  
CYP450s are a large and ancient enzyme family that has an important role in detoxification of 
chemicals in invertebrates as well as vertebrates [1,7,10-12].  As will be discussed later, this 
detoxification function may have been important in the co-evolution of steroids and nuclear 
receptors [1,7]. 
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Figure 1. Structures of adrenal and sex steroids. 
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Figure 2. Enzymes involved in the synthesis of vertebrate steroids from cholesterol 
CYP450s, 3 /
5-4
 HSD and 17 -HSD-type 2 catalyze the formation of vertebrate steroids from 
cholesterol [4-5,7,10-12].  CYP11A and CYP19 are present in amphioxus [7,37,40,63].  
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steroids, such as 
5
-androstenediol, may be ancestral ligands for the ER [6,42].  Similarly, 
deoxycorticosterone may be the ancestral mineralocorticoid [64-65]  
 
To understand the evolution of steroids it is important to consider when nuclear receptors, 
in general, and adrenal and sex steroid receptors in particular, evolved, and how this correlates 
with the evolution of enzymes involved in steroid synthesis.  We begin with the origins of 
nuclear receptors. 
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Nuclear receptors are unique to multicellular animals. 
The availability of complete genomes from bacteria, yeast, plants, invertebrates and 
vertebrates has increased our understanding of the origins of various transcription factors, 
including nuclear receptors.  Searches of Genbank did not find any nuclear receptors in the 
yeast Saccharomyces cerevisiae [16] or in the plant Arabidopsis [17].  This was surprising 
because nuclear receptors, such as the estrogen receptor (ER) [18] and glucocorticoid receptor 
(GR) [19], can function nicely when transfected into yeast along with a reporter gene.  
Similarly, the glucocorticoid receptor can function when transfected into Arabidopsis [20].  
This indicates that the basic machinery for transcriptional activation by nuclear receptors evolved 
in the common ancestor of fungi and metazoans, even if this ancestor did not contain nuclear 
receptors. 
In fact, nuclear receptors are found in sponges and simple multicellular animals [21-23].  
The “sudden” appearance of nuclear receptors in basal multicellular animals, suggests that 
nuclear receptors had an important role in this important evolutionary transition. 
 
When did steroid receptors evolve? 
The origins of steroid receptors have been a subject of much interest [24-27].  In 1997, 
two different analyses suggested that steroid receptors arose in deuterostomes [Figure 3].  
Escriva et al [26] used PCR to investigate the presence of steroid and thyroid hormone receptors 
and other nuclear receptors in various deuterostomes and protostomes.  They found evidence 
for steroid receptors in hagfishes, but not in sea urchin or acorn worm, which are at the base of 
the deuterostome line.  Nor did they find an ortholog of an adrenal or sex steroid receptor in a 
protostome.  This suggested that steroid binding arose late in metazoan evolution in a primitive 
deuterostome. 
A similar conclusion came from an alternative approach using a phylogenetic analysis of 
the ligand-binding domains of receptors for steroids, thyroid hormone, retinoids, vitamin D and 
ecdysone [24].  This phylogenetic analysis indicated that steroid receptors arose at the base of 
the vertebrate line, in an ancestral cephalochordate [e.g. amphioxus] or urochordate [e.g. Ciona].  
It predicted that orthologs of adrenal and sex steroid receptors would not be found in the 
genomes of either Caenorhabditis elegans or Drosophila, which were still being sequenced.  
This analysis also proposed that the ER was the ancestral steroid receptor, and that a duplication 
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of this ER followed by sequence divergence and further duplications led to the androgen receptor 
(AR), GR, mineralocorticoid receptor (MR) and progesterone receptor (PR).  It also suggested  
 
 
 
Figure 3. Estrogen-binding nuclear receptors in metazoans 
Amphioxus contains an ortholog of vertebrate ERs.  Annelids contain nuclear receptors that are 
activated by estradiol [49].  Nuclear receptors with sequence similarity to vertebrate ERs are 
found in mollusks, and these receptors do not bind estradiol [43-45,47-48].  Amphioxus also 
contains an SR, which is an ancestor of 3keto-steroid receptors found in vertebrates [not shown]. 
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that the ancestral ER had functions that differed from its well studied reproductive functions in 
mammals [28].  Indeed, since the transition from amphioxus to lamprey involves the evolution 
of the head [29-32] [Figure 4], it seemed reasonable to propose a role for the ER in the evolution 
of a more complex brain in vertebrates [24].  As more nuclear receptor sequences became 
available, the phylogenetic evidence for the ER as the ancestral steroid receptor became stronger 
[25].  It was the cloning of the lamprey ER, PR and corticoid receptors by Thornton [27] that 
firmly established that the ER was the ancestral steroid receptor. 
 
 
 
  
Figure 4. Evolution of the head in amphioxus [29-32] 
The notochord extends right to the front of amphioxus.  In contrast, the vertebrate has a 
prominent head at the anterior end, extending beyond the notochord.  Modified from [29]. 
 
A role for steroid receptors in vertebrate evolution? 
In 2001, the human genome was sequenced and found to have about 33,000 genes, which 
were many fewer than previously thought, and not much more than the ~18,000 genes in C. 
elegans and ~13,000 genes in Drosophila.  Since then, these genomes have been analyzed 
further and the human, C. elegans and Drosophila genomes are now estimated to contain 
~23,500, ~20,000 and ~14,000 genes, respectively.  These revisions make the low number of 
genes in the human genome relative to C. elegans and Drosophila even more perplexing.  
Several explanations have been advanced to explain the relatively small difference between the 
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number of genes in the genomes of humans, worms and flies including alternative splicing, the 
presence of multiple domains in vertebrate proteins, which increases the complexity of 
protein-protein interactions, post-translational modifications of vertebrate proteins and the 
evolution of networks of transcription factors [see [28] for original references]. 
Another explanation that was proposed for complex differentiation and development in 
vertebrates was the emergence of one or more steroid receptors in amphioxus, a basal chordate 
[28].  Subsequent expansion and diversification of these receptors as a result of two genome 
size duplications, which occurred between the evolution of amphioxus and agnathostomes [e.g. 
lamprey, hagfish] [33], yielded the adrenal and sex steroid receptors [28].  This hypothesis that 
steroid receptors arose in amphioxus and expanded and diversified during the interval leading to 
basal vertebrates was based on searches of GenBank that did not find invertebrate ancestors of 
vertebrate steroid receptors or of steroid dehydrogenases [7,13,15,34].  If the suite of steroid 
receptors and steroid dehydrogenases that are essential for the adrenal and sex steroid response 
arose and diversified at the base of the vertebrate line, then it would provide an additional means 
for regulating differentiation, development and homeostasis, and contribute to the evolution of 
complex regulatory networks [e.g. nervous and immune systems] found in vertebrates. 
Amphioxus contains steroid receptors 
Recent studies support the presence of steroid signaling in amphioxus (Branchiostoma 
floridae) and B. belcheri [35-39].  Key enzymes for the synthesis of testosterone and estradiol 
are present in amphioxus [37,40].  Moreover, there is an ER in B. floridae (BfER) [36,38] and B. 
belcheri (BbER) [39] and steroid receptors (BfSR and BbSR), which are phylogenetically closest 
to 3keto-steroid receptors[36,39].  Unexpectedly, BfER and BbER are not activated by estradiol 
or other steroids [36,38-39].  In contrast, BfSR and BbSR activate transcription in the presence 
of E2 and estrone (E1), but not in the presence of 3keto-steroids [36,39].  Interestingly, BfER 
and BbER repress activation of BfSR and BbSR, respectively, by E2, suggesting a novel 
cross-regulatory interaction between these two receptors.  The affinity of E2 for BfSR is about 
100 nM [36], which makes it unlikely that E2 is the physiological ligand [41].  Other steroids 
may be the physiological ligands [6,35,42] 
Invertebrate ERs in mollusks. 
The origins steroid receptors became more complex with the cloning of a nuclear 
receptor that had strong sequence similarity to the human ER from Aplysia californica [43].  
The sequence of the DNA-binding domain of Aplysia ER is 79% and 65% identical, respectively, 
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to the DNA-binding domain on human ER and ERR.  This indicates a deep conservation of the 
interaction of between the hormone response element and the DNA-binding domains on human 
ER, human ERR and Aplysia ER. 
In contrast, the ligand-binding domain of Aplysia ER is about 35% identical to human ER 
after insertion of gaps at 17 positions in the alignment, which indicates substantial divergence in 
their ligand-binding domains.  Interestingly, Aplysia ER is about 32% identical to human ERR 
with gaps at 5 positions.  Analysis of the ligand-binding domain on octopus ER, another 
invertebrate ER [44], reveals that it is 33% identical to human ER , after insertion of gaps at 21 
positions in the alignment.  Octopus ER is 29% identical to human ERR, after insertion of gaps 
at 5 positions.  An explanation for the fewer gaps in the alignments of the ligand-binding 
domain on octopus ER and Aplysis ER with human ERR is that their lengths are shorter than the 
ligand-binding domain of human ER  [45-46]. . Aplysia ER and octopus ER do not bind E2 or 
other steroids.  In fact, the Aplysia ER and octopus ER constitutively regulate gene transcription 
in the absence of E2 or other steroids.  In both of these biological properties, Aplysia ER and 
octopus ER are similar to human ERR [46].  As happens with intriguing discoveries, soon other 
invertebrate receptors with sequence similarity to vertebrate ERs were cloned from snails [47] 
andscallops [48].  These invertebrate receptors also were constitutively active and did not bind 
E2 or other steroids. 
An insight into the basis for the absence of E2 binding to octopus ER came from a 3D 
model of octopus ER complexed with E2, which revealed that the ligand-binding site on octopus 
ER was too small to contain E2 [45].  As a result, there were steric clashes between E2 and side 
chains in octopus ER, which prevented E2 from occupying octopus ER, providing an explanation 
for the absence of steroid binding.  The small ligand-binding pocket in octopus ER is consistent 
with is shorter sequence [45-46].  Similar to the 3D model of octopus ER with E2, Greschik et 
al [46] showed that in human ERR  the ligand binding site is occupied by side chains from 
neighboring amino acids, which prevent binding of E2. 
Annelid nuclear receptors bind estradiol 
Recently, nuclear receptors from two annelids, Platynereis dumerilii and Capitella 
capitata, were found to regulate gene transcription in the presence of E2 [49].  Measurements 
of transcription in cells transfected with the P. dumerilii receptor yielded an EC50 of 8.5 nM for 
E2.  In the presence of 1 M E2, the P. dumerilii receptor increased transcription by about 
3.5-fold over controls.  At 10 nM E2, transcription increased by about 2-fold, which does not 
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appear to be physiological by mammalian standards for E2 activation of ER  and is substantially 
lower than the ~35-fold increase in activity for human ER  in the presence of 10 nM E2 [49].  
Various in vivo conditions may lead to the P. dumerilii ER having a stronger response to E2 at 
lower concentrations: It may be that there are specific coactivators in P. dumerilii that are 
necessary for optimal transcriptional activity of its receptor in the presence of E2;  Or perhaps 
there are post-translational modifications of this receptor in P. dumerilii that increase its response 
to E2;  Or physiological activity of the P. dumerilii receptor may require the DNA-binding 
sequence in P. dumerilii [50].  Another explanation is that E2 may not be the physiological 
ligand for the P. dumerilii receptor.  Deciphering the ligands and the biological function(s) of 
the P. dumerilii receptor for E2 will yield important information about ligand-activated nuclear 
receptors in annelids, which are still poorly understood. 
Divergent Evolution, Convergent Evolution, Horizontal Transfer? 
The presence of estrogen receptor-like nuclear receptors in mollusks and annelids leaves 
the origins of steroid receptor signaling unsettled.  There are at least three possible explanations 
for these data.  One explanation is that the mollusk, annelid and vertebrate receptors are an 
example of divergent evolution from an ancestral steroid receptor, which evolved in a common 
ancestor of protostomes and deuterostomes [43,49].  Subsequently, in some mollusks, 
mutations in this steroid receptor resulted in the loss of E2 binding and the evolution of 
constitutive activity.  In other organisms, such as flies and worms, the ancestral ER gene was 
lost. 
A second explanation, which we favor, is that the similarities between invertebrate ERs 
and vertebrate ERs are an example of convergent evolution from an ancestral ERR [2,21].  As 
noted previously, convergent evolution is common in steroid binding proteins [13].  Indeed, 
high affinity binding for E2 is found in vertebrate ERs, rat and mouse alpha-fetoprotein and sex 
steroid binding globulin [13], as well as in enzymes in yeast [51], which do not have steroid 
receptors.  Another example of convergence is the presence of over ten 17 -hydroxysteroid 
dehydrogenases that metabolize estrogens and androgens [13-14,52]. 
This explanation is consistent with the similarities in the structural properties of octopus 
ER and human ERR [45], which support the closeness of octopus ER to human ERR.  Similarly, 
binding of E2 by receptors in P. dumerilii and C. capitata may have evolved through convergent 
evolution from an ancestral ERR.  Interestingly, conversion of human ERR  to bind E2 has 
been accomplished by Greschik et al. [46] by mutation of two residues in the ligand binding 
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pocket.  However, this mutant ERR  remained constitutively active.  Understanding the 
relationship of the structure of the P. dumerilii ER-like receptor to ERRs and vertebrate ERs 
should elucidate steps in evolution of ligand-activated receptors from constitutive receptors. 
A third explanation is that there was horizontal transfer between a protostome and 
deuterostome.  Horizontal transfer is common in prokaryotes [53] and rare in eukaryotes, 
especially multi-cellular animals.  Nevertheless this possibility must be considered. 
It is clear that at this time that there are unresolved questions about the evolution of 
steroid receptors in metazoans.  Thus, there is a need for alternative methods to investigate the 
origins of steroid hormone signaling. 
Origin of key steroidogenic enzymes in amphioxus 
Fortunately, an examination of the origins of steroidogenic enzymes [1,7,28] provides an 
alternate approach to understanding the origins of steroid hormone signaling.  When did the 
enzymes that synthesize E2 and other vertebrate steroids evolve?  The evolution of CYP11A, 
which catalyzes the cleavage of the cholesterol side chain to form pregnenolone, and CYP19, 
which catalyzes the formation of estradiol from testosterone [Figure 2] [5,11] provide important 
clues to the origin of signaling by vertebrate steroids.  Orthologs of both enzymes have been 
cloned from amphioxus [37,40].  A recent extensive search of GenBank by Markov et al [7] did 
not find evidence for a CYP11A or CYP19 in species other than amphioxus or vertebrates, 
suggesting that these enzymes arose in the ancestor of chordates. 
Further support comes from database searches for orthologs of 17 -HSD-type 1 and 
17 -HSD -type 2, which are involved in estrogen synthesis [14-15,25].  There are many 
17 -HSD homologs in invertebrates, for which the biological substrate has not been determined 
[14].  However, at this time, orthologs of 17 -HSD-type 1 and 17 -HSD -type 2 have been 
found only in vertebrates [7]. 
These recent database searches indicate that some of the key enzymes involved in the 
synthesis of adrenal and sex steroids first evolved in amphioxus, when the ligand-activated BfSR 
and BbSR first appear.  Of course, as noted by Markov et al [7], there may have been 
convergent evolution for aromatase activity in invertebrates.  Similarly, convergent evolution 
could have led to CYP11A, 17 -HSD1 and 17 -HSD2 activities in invertebrates. 
These studies raise the question of how vertebrate steroids and their receptors evolved 
from an ancestral nuclear receptor, which we discuss next. 
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Role of CYP450 metabolism of sterols and xenobiotics in the ancestry of steroidogenic 
enzymes 
CYP450s are ancient enzymes, which are found in bacteria, yeast and basal metazoans 
[7,10-12].  CYP450s evolved through gene duplication and divergence into a diverse protein 
family that metabolizes a wide variety of chemicals.  Two functions of ancient CYP450s 
provide clues to the evolution of vertebrate steroids.  First, CYP450s catalyze the synthesis of 
sterols, such as oxysterols and bile acids from cholesterol [Figure 3].  Sterols and bile acids 
regulate gene transcription by binding to nuclear receptors [1,7-8,54-55].  Oxysterols are 
ligands for the liver X receptor [LXR], which acts as an oxysterol sensor [54-55], and bile acids 
are ligands for the farnesoid X receptor [FXR], vitamin D receptor [VDR] and pregnane X 
receptor [PXR] [54-55].  In insects and crustaceans, CYP450s also catalyze the synthesis of 
20-hydroxyecdysone from cholesterol.  20-hydroxyecdysone regulates development and 
reproduction in arthropods through binding to the ecdysone receptor, which belongs to the 
nuclear receptor family [2,8]. 
A second function of invertebrate and vertebrate CYP450s is to hydroxylate a wide 
variety of xenobiotics, as part of the process for removing toxic chemicals.  A recent 
phylogenetic analysis found that some CYP450s that synthesize steroids [Figure 2] evolved from 
CYP450s involved in detoxification of xenobiotics [7]. 
At this time, the identity of the ligand(s) that activated the ancestral ER is not known.  
The vertebrate ER is notable for binding of environmental chemicals with diverse structures 
[56-57], the ancestral ER may have been a xenobiotic sensor [7].  The binding of many 
xenobiotics and natural products to the ER is consistent with recent evidence that the vertebrate 
ER has conformational flexibility, which allows it to bind diverse ligands, including 
27-hydroxycholesterol [58-59] [Figure 5], trifluoromethyl-phenylvinyl-E2 [60], as well as 
tamoxifen and diethylstilbestrol.  Thus, there may have been several classes of ligands, 
including sterols, xenobiotics and natural chemicals that were the original ligand(s) for the 
ancestral ER. 
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FIG.5. Structures of 27-hydroxycholesterol and bile acids. 
Cholesterol is a precursor for oxysterols and bile acids, both of which bind to nuclear receptors 
and regulate gene transcription [54-55].  These ligands include 27-hydroxy-cholesterol, an 
oxysterol, andcholic acid, and lithocholic acid, which are bile acids..  Oxysterols are ligands for 
the liver X receptor [LXR] [54-55]; bile acids are ligands for the farnesoid X receptor [FXR], 
vitamin D receptor [VDR] and pregnane X receptor [PXR] [54-55]. 
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In summary, searches of recently completed deuterostome and protostome genomes for 
orthologs of vertebrate steroid receptors and steroidogenic enzymes support an earlier hypothesis 
that the ligand-activated ER and other vertebrate steroid receptors evolved in a deuterostome 
[3,7,25-26].  The close sequence and structural similarity of the invertebrate ERs and ERR [46] 
and the presence of ERRs in primitive metazoans [2,21] suggests that the ancestral invertebrate 
ER evolved from an ERR and the ER ancestors was likely to have been constitutively active.  
This leaves unresolved how ligand activation of the vertebrate ER evolved from a constitutively 
active ancestor, which appears to be a complex process because a mutant human ERR that binds 
E2 [46] and a mutant Drosophila ERR [61] that binds diethylstilbestrol have been constructed 
and neither activates transcription with the bound ligand.  The mutant human ERR complexed 
with E2 is constitutively active [46].  Interestingly, binding of diethylstilbestrol to the mutant 
Drosphila ERR represses constitutive activity [61].  Further complicating the relationship 
between binding of E2 to the ER and transcriptional activity is the evidence that, point mutations 
in ER  lead to a constitutively active receptor [62].  Sorting out these latter steps in evolution 
of a ligand-activated ER is an important next task in the deciphering the evolution of adrenal and 
sex steroid action. 
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